病态肥胖患者行全髋或全膝关节置换术前实验室指标预测假体周围关节感染
基于Premier医疗数据库的病态肥胖(BMI≥40 kg/m²)初次择期全髋或全膝关节置换患者共6,780例,其中47例(0.69%)在术后90天内发生假体周围关节感染。多因素回归显示术前贫血、血小板计数异常及中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值、系统免疫炎症指数升高与假体周围关节感染风险增加相关。
要点
- 病态肥胖患者术后90天假体周围关节感染率为0.69%。
- 术前血红蛋白降低、血小板计数异常及NLR、PLR、SII升高与PJI风险增加相关。
- 上述指标可能有助于外科医生对该高危人群进行风险分层。
核心结论
- 术前贫血、血小板计数异常以及NLR、PLR、SII升高与体重指数≥40 kg/m²患者假体周围关节感染风险增加相关。
- 这些发现可能有助于外科医生对该高危患者人群进行风险分层。
研究设计与样本
- 利用Premier医疗数据库识别所有在初次择期全膝关节置换或全髋关节置换术前具有术前实验室数据的病态肥胖患者。
- 共识别6,780例患者,其中全膝关节置换占76.67%,全髋关节置换占23.33%。
- 比较术后90天内发生假体周围关节感染的患者与未发生假体周围关节感染的患者。
- 实验室阈值由临床指南或原始文献定义。
- 采用单因素和多因素回归分析评估假体周围关节感染与术前实验室指标之间的关联。
主要发现
- 6,780例患者中47例(0.69%)在术后90天内发生假体周围关节感染。
- 血红蛋白水平低于12 g/dL(女性)或低于13 g/dL(男性)的患者假体周围关节感染率为1.69%。
- 血小板计数低于142,000/µL或高于417,000/µL的患者假体周围关节感染率为2.14%。
- 中性粒细胞-淋巴细胞比值高于3.31的患者假体周围关节感染率为1.11%。
- 血小板-淋巴细胞比值高于182.3的患者假体周围关节感染率为1.69%,系统免疫炎症指数高于776.2的患者假体周围关节感染率为1.05%。
关键数值与推荐
- 校正潜在混杂因素后,术前中性粒细胞-淋巴细胞比值异常与假体周围关节感染相关(aOR 2.38,95%CI 1.04至5.44,p=0.039)。
- 校正潜在混杂因素后,术前血小板-淋巴细胞比值异常与假体周围关节感染相关(aOR 4.86,95%CI 2.15至10.95,p<0.001)。
- 校正潜在混杂因素后,术前系统免疫炎症指数异常与假体周围关节感染相关(aOR 2.44,95%CI 1.09至5.44,p=0.029)。
- 校正潜在混杂因素后,术前血小板计数异常与假体周围关节感染相关(aOR 3.50,95%CI 1.11至10.99,p=0.032)。
- 校正潜在混杂因素后,术前血红蛋白水平异常与假体周围关节感染相关(aOR 2.62,95%CI 1.06至6.50,p=0.038)。
临床怎么用
- 作者认为这些发现可能有助于外科医生对体重指数≥40 kg/m²这一高危患者人群进行风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Morbidly obese patients are an ever-growing high-risk population undergoing total hip arthroplasty (THA) and total knee arthroplasty (TKA) for end-stage osteoarthritis. This study sought to identify preoperative laboratory values that may serve as predictors of periprosthetic joint infection (PJI) in morbidly obese patients undergoing THA or TKA. METHODS: All morbidly obese patients with preoperative laboratory data before undergoing primary elective TKA or THA were identified using the Premier Healthcare Database. Patients who developed PJI within 90 days after surgery were compared with patients without PJI. Laboratory value thresholds were defined by clinical guidelines or primary literature. Univariate and multivariable regression analyses were utilized to assess the association between PJI and preoperative laboratory values, including total lymphocyte count, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), albumin level, platelet count, albumin-globulin ratio, hemoglobin level, and hemoglobin A1c. RESULTS: Of the 6,780 patients identified (TKA: 76.67%; THA: 23.33%), 47 (0.69%) developed PJI within 90 days after surgery. The rate of PJI was 1.69% for patients with a hemoglobin level of <12 g/dL (for females) or <13 g/dL (for males), 2.14% for those with a platelet count of <142,000/µL or >417,000/µL, 1.11% for those with an NLR of >3.31, 1.69% for those with a PLR of >182.3, and 1.05% for those with an SII of >776.2. After accounting for potential confounding factors, we observed an association between PJI and an abnormal preoperative NLR (adjusted odds ratio [aOR]: 2.38, 95% confidence interval [CI]: 1.04 to 5.44, p = 0.039), PLR (aOR: 4.86, 95% CI: 2.15 to 10.95, p < 0.001), SII (aOR: 2.44, 95% CI: 1.09 to 5.44, p = 0.029), platelet count (aOR: 3.50, 95% CI: 1.11 to 10.99, p = 0.032), and hemoglobin level (aOR: 2.62, 95% CI: 1.06 to 6.50, p = 0.038). CONCLUSIONS: This study identified preoperative anemia, abnormal platelet count, and elevated NLR, PLR, and SII to be associated with an increased risk of PJI among patients with a body mass index of ≥40 kg/m 2 . These findings may help surgeons risk-stratify this high-risk patient population. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Telang S, Mayfield CK, Palmer R, et al. Preoperative Laboratory Values Predicting Periprosthetic Joint Infection in Morbidly Obese Patients Undergoing Total Hip or Knee Arthroplasty. J Bone Joint Surg Am. 2024. PMID: 38941451. doi:10.2106/JBJS.23.01360
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。